Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations - Concepedia

Concepedia

Publication | Closed Access

Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations

22

Citations

28

References

2021

Year

Jing Xu, Tanya E. Keenan, Beth Overmoyer, Nadine Tung, Rebecca Gelman, Karleen Habin, Judy E. Garber, Leif W. Ellisen, Eric P. Winer, Paul E. Goss,

Breast Cancer Research and Treatment

Breast OncologyPhase Ii TrialMedicineBrca1/2 MutationsPharmacologyPathologyBreast CancerAnti-cancer AgentCancer TreatmentOncologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1